BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26376850)

  • 1. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
    Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
    J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum proteome components associated with progression of non-small cell lung cancer.
    Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
    Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
    Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Search for potential gastric cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry].
    Shevchenko VE; Arnotskaia NE; Ogorodnikova EV; Davydov MM; Ibraev MA; Turkin IN; Davydov MI
    Biomed Khim; 2014; 60(4):503-14. PubMed ID: 25249535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy--A Pilot Study.
    Widlak P; Jelonek K; Wojakowska A; Pietrowska M; Polanska J; Marczak Ł; Miszczyk L; Składowski K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1108-1115. PubMed ID: 26031365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
    Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.
    Hortin GL
    Clin Chem; 2006 Jul; 52(7):1223-37. PubMed ID: 16644871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing of MALDI-ToF-based low-molecular-weight serum proteome pattern analysis in detection of breast cancer patients; the effect of albumin removal on classification performance.
    Pietrowska M; Marczak L; Polanska J; Nowicka E; Behrent K; Tarnawski R; Stobiecki M; Polanski A; Widlak P
    Neoplasma; 2010; 57(6):537-44. PubMed ID: 20845992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
    Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
    Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
    Shen J; Zhai J; Wu X; Xie G; Shen L
    J Cell Mol Med; 2020 Jun; 24(12):6750-6761. PubMed ID: 32363730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
    Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
    BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum peptidome profiling in patients with gastric cancer.
    Yang J; Song YC; Dang CX; Song TS; Liu ZG; Guo YM; Li ZF; Huang C
    Clin Exp Med; 2012 Jun; 12(2):79-87. PubMed ID: 21739109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profiling reveals gender differences in the composition of human serum.
    Miike K; Aoki M; Yamashita R; Takegawa Y; Saya H; Miike T; Yamamura K
    Proteomics; 2010 Jul; 10(14):2678-91. PubMed ID: 20480504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.